+1 347 708 0418
Long Acting Insulins market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long Acting Insulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Segment by Application
Home Use
Medical Institutions
Others
By Company
Novo Nordisk
Sanofi
Wockhardt UK
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Insulin Glargine
1.2.3 Insulin Determir
1.2.4 Insulin Degludec
1.2.5 Long Acting Animal Insulin
1.3 Market by Application
1.3.1 Global Long Acting Insulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Insulins Market Perspective (2017-2028)
2.2 Long Acting Insulins Growth Trends by Region
2.2.1 Long Acting Insulins Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long Acting Insulins Historic Market Size by Region (2017-2022)
2.2.3 Long Acting Insulins Forecasted Market Size by Region (2023-2028)
2.3 Long Acting Insulins Market Dynamics
2.3.1 Long Acting Insulins Industry Trends
2.3.2 Long Acting Insulins Market Drivers
2.3.3 Long Acting Insulins Market Challenges
2.3.4 Long Acting Insulins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Insulins Players by Revenue
3.1.1 Global Top Long Acting Insulins Players by Revenue (2017-2022)
3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2017-2022)
3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Insulins Revenue
3.4 Global Long Acting Insulins Market Concentration Ratio
3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2021
3.5 Long Acting Insulins Key Players Head office and Area Served
3.6 Key Players Long Acting Insulins Product Solution and Service
3.7 Date of Enter into Long Acting Insulins Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Insulins Breakdown Data by Type
4.1 Global Long Acting Insulins Historic Market Size by Type (2017-2022)
4.2 Global Long Acting Insulins Forecasted Market Size by Type (2023-2028)
5 Long Acting Insulins Breakdown Data by Application
5.1 Global Long Acting Insulins Historic Market Size by Application (2017-2022)
5.2 Global Long Acting Insulins Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long Acting Insulins Market Size (2017-2028)
6.2 North America Long Acting Insulins Market Size by Type
6.2.1 North America Long Acting Insulins Market Size by Type (2017-2022)
6.2.2 North America Long Acting Insulins Market Size by Type (2023-2028)
6.2.3 North America Long Acting Insulins Market Share by Type (2017-2028)
6.3 North America Long Acting Insulins Market Size by Application
6.3.1 North America Long Acting Insulins Market Size by Application (2017-2022)
6.3.2 North America Long Acting Insulins Market Size by Application (2023-2028)
6.3.3 North America Long Acting Insulins Market Share by Application (2017-2028)
6.4 North America Long Acting Insulins Market Size by Country
6.4.1 North America Long Acting Insulins Market Size by Country (2017-2022)
6.4.2 North America Long Acting Insulins Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Long Acting Insulins Market Size (2017-2028)
7.2 Europe Long Acting Insulins Market Size by Type
7.2.1 Europe Long Acting Insulins Market Size by Type (2017-2022)
7.2.2 Europe Long Acting Insulins Market Size by Type (2023-2028)
7.2.3 Europe Long Acting Insulins Market Share by Type (2017-2028)
7.3 Europe Long Acting Insulins Market Size by Application
7.3.1 Europe Long Acting Insulins Market Size by Application (2017-2022)
7.3.2 Europe Long Acting Insulins Market Size by Application (2023-2028)
7.3.3 Europe Long Acting Insulins Market Share by Application (2017-2028)
7.4 Europe Long Acting Insulins Market Size by Country
7.4.1 Europe Long Acting Insulins Market Size by Country (2017-2022)
7.4.2 Europe Long Acting Insulins Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Insulins Market Size (2017-2028)
8.2 Asia-Pacific Long Acting Insulins Market Size by Type
8.2.1 Asia-Pacific Long Acting Insulins Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Long Acting Insulins Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Long Acting Insulins Market Share by Type (2017-2028)
8.3 Asia-Pacific Long Acting Insulins Market Size by Application
8.3.1 Asia-Pacific Long Acting Insulins Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Long Acting Insulins Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Long Acting Insulins Market Share by Application (2017-2028)
8.4 Asia-Pacific Long Acting Insulins Market Size by Region
8.4.1 Asia-Pacific Long Acting Insulins Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Long Acting Insulins Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Long Acting Insulins Market Size (2017-2028)
9.2 Latin America Long Acting Insulins Market Size by Type
9.2.1 Latin America Long Acting Insulins Market Size by Type (2017-2022)
9.2.2 Latin America Long Acting Insulins Market Size by Type (2023-2028)
9.2.3 Latin America Long Acting Insulins Market Share by Type (2017-2028)
9.3 Latin America Long Acting Insulins Market Size by Application
9.3.1 Latin America Long Acting Insulins Market Size by Application (2017-2022)
9.3.2 Latin America Long Acting Insulins Market Size by Application (2023-2028)
9.3.3 Latin America Long Acting Insulins Market Share by Application (2017-2028)
9.4 Latin America Long Acting Insulins Market Size by Country
9.4.1 Latin America Long Acting Insulins Market Size by Country (2017-2022)
9.4.2 Latin America Long Acting Insulins Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Insulins Market Size (2017-2028)
10.2 Middle East & Africa Long Acting Insulins Market Size by Type
10.2.1 Middle East & Africa Long Acting Insulins Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Long Acting Insulins Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Long Acting Insulins Market Share by Type (2017-2028)
10.3 Middle East & Africa Long Acting Insulins Market Size by Application
10.3.1 Middle East & Africa Long Acting Insulins Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Long Acting Insulins Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Long Acting Insulins Market Share by Application (2017-2028)
10.4 Middle East & Africa Long Acting Insulins Market Size by Country
10.4.1 Middle East & Africa Long Acting Insulins Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Long Acting Insulins Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Long Acting Insulins Introduction
11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2017-2022)
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Long Acting Insulins Introduction
11.2.4 Sanofi Revenue in Long Acting Insulins Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 Wockhardt UK
11.3.1 Wockhardt UK Company Details
11.3.2 Wockhardt UK Business Overview
11.3.3 Wockhardt UK Long Acting Insulins Introduction
11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2017-2022)
11.3.5 Wockhardt UK Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Insulin Glargine
Table 3. Key Players of Insulin Determir
Table 4. Key Players of Insulin Degludec
Table 5. Key Players of Long Acting Animal Insulin
Table 6. Global Long Acting Insulins Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Long Acting Insulins Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Long Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Long Acting Insulins Market Share by Region (2017-2022)
Table 10. Global Long Acting Insulins Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Long Acting Insulins Market Share by Region (2023-2028)
Table 12. Long Acting Insulins Market Trends
Table 13. Long Acting Insulins Market Drivers
Table 14. Long Acting Insulins Market Challenges
Table 15. Long Acting Insulins Market Restraints
Table 16. Global Long Acting Insulins Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Long Acting Insulins Revenue Share by Players (2017-2022)
Table 18. Global Top Long Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2021)
Table 19. Ranking of Global Top Long Acting Insulins Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Long Acting Insulins Product Solution and Service
Table 23. Date of Enter into Long Acting Insulins Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Long Acting Insulins Revenue Market Share by Type (2017-2022)
Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Long Acting Insulins Revenue Market Share by Type (2023-2028)
Table 29. Global Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Long Acting Insulins Revenue Share by Application (2017-2022)
Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Long Acting Insulins Revenue Share by Application (2023-2028)
Table 33. North America Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Long Acting Insulins Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Long Acting Insulins Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Long Acting Insulins Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Long Acting Insulins Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Long Acting Insulins Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Long Acting Insulins Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Long Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Long Acting Insulins Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Long Acting Insulins Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Long Acting Insulins Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Long Acting Insulins Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Long Acting Insulins Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 63. Novo Nordisk Company Details
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Long Acting Insulins Product
Table 66. Novo Nordisk Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
Table 67. Novo Nordisk Recent Developments
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Long Acting Insulins Product
Table 71. Sanofi Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
Table 72. Sanofi Recent Developments
Table 73. Wockhardt UK Company Details
Table 74. Wockhardt UK Business Overview
Table 75. Wockhardt UK Long Acting Insulins Product
Table 76. Wockhardt UK Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
Table 77. Wockhardt UK Recent Developments
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Insulins Market Share by Type: 2021 VS 2028
Figure 2. Insulin Glargine Features
Figure 3. Insulin Determir Features
Figure 4. Insulin Degludec Features
Figure 5. Long Acting Animal Insulin Features
Figure 6. Global Long Acting Insulins Market Share by Application: 2021 VS 2028
Figure 7. Home Use Case Studies
Figure 8. Medical Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. Long Acting Insulins Report Years Considered
Figure 11. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Long Acting Insulins Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Long Acting Insulins Market Share by Region: 2021 VS 2028
Figure 14. Global Long Acting Insulins Market Share by Players in 2021
Figure 15. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2021
Figure 17. North America Long Acting Insulins Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Long Acting Insulins Market Size Market Share by Type (2017-2028)
Figure 19. North America Long Acting Insulins Market Size Market Share by Application (2017-2028)
Figure 20. North America Long Acting Insulins Market Size Share by Country (2017-2028)
Figure 21. United States Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Long Acting Insulins Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Long Acting Insulins Market Size Market Share by Type (2017-2028)
Figure 25. Europe Long Acting Insulins Market Size Market Share by Application (2017-2028)
Figure 26. Europe Long Acting Insulins Market Size Share by Country (2017-2028)
Figure 27. Germany Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Long Acting Insulins Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Long Acting Insulins Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Long Acting Insulins Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Long Acting Insulins Market Size Share by Region (2017-2028)
Figure 37. China Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Long Acting Insulins Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Long Acting Insulins Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Long Acting Insulins Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Long Acting Insulins Market Size Share by Country (2017-2028)
Figure 47. Mexico Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Long Acting Insulins Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Long Acting Insulins Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Long Acting Insulins Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Long Acting Insulins Market Size Share by Country (2017-2028)
Figure 53. Turkey Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
Figure 58. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Buy
